NASDAQ:DBVT

Dbv Technologies S.a Stock News

etoro logo Buy DBVT
*Your capital is at risk
$15.82
+0.0900 (+0.572%)
At Close: Jul 02, 2026
Montrouge, France, April 30, 2020 DBV Technologies Reports March 31, 2020 Cash Position DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a.

61 Stocks Moving In Thursday's Mid-Day Session

04:43pm, Thursday, 30'th Apr 2020
Gainers AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares climbed 76.1% to $4.05 after jumping 160% on Wednesday. QEP Resources, Inc. (NYSE: QEP) shares climbed 46.2% to $1.05...

OSTK, AR among premarket gainers

01:20pm, Thursday, 30'th Apr 2020
LMP Automotive Holdings (NASDAQ:LMPX) +35%.AgEagle Aerial Systems (NYSEMKT:UAVS) +27%.Soligenix (NASDAQ:SNGX) +25% on positive SGX301 data.Secoo Holding (NASDAQ:SECO) +26% on share repurchase progra

35 Stocks Moving in Thursday's Pre-Market Session

11:11am, Thursday, 30'th Apr 2020
Gainers QEP Resources, Inc. (NYSE: QEP) shares rose 68.5% to $1.21 in pre-market trading after the company reported strong Q1 earnings. AgEagle Aerial Systems, Inc. (NYSE: UAVS)...
Gainers • Chimerix, Inc. (NASDAQ:CMRX) shares increased by 38.41% to $2.09 during Wednesday's pre-market session. • Accuray, Inc. (NASDAQ:ARAY) shares increased by...
The "Global Allergy Immunotherapies Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
AIMT is currently near its 52-week lows after Palforzia's approval. The bullish view differs with the bearish one on the commercial potentia issue. Here I weigh

70 Biggest Movers From Yesterday

08:12am, Thursday, 23'rd Apr 2020
Gainers SAExploration Holdings, Inc. (NASDAQ: SAEX) shares surged 98.2% to close at $2.22 on Wednesday after the company disclosed a new project in Greece. The Peck Company...
Montrouge, France, April 20, 2020 DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting Shareholders approve all proposed resolutions DBV.

Is Aimmune Therapeutics a Buy?

11:09am, Friday, 17'th Apr 2020
A recent drug approval, a competitor's setback, and a discounted stock price make Aimmune an intriguing investment.
DBV Technologies and Aimmune are at the finish line for developing novel therapies for treating peanut allergies, but each has its own twist.
DBV TECHNOLOGIE/S (NASDAQ:DBVT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Tuesday, Zacks.com reports. The brokerage currentl
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE